AR045612A1 - COMBINATION OF INHIBITORS OF THE RECOVERY OF SEROTONINE AND INHIBITORS OF THE RECAPTATION OF NOREPINEFRINE - Google Patents
COMBINATION OF INHIBITORS OF THE RECOVERY OF SEROTONINE AND INHIBITORS OF THE RECAPTATION OF NOREPINEFRINEInfo
- Publication number
- AR045612A1 AR045612A1 ARP040103219A AR045612A1 AR 045612 A1 AR045612 A1 AR 045612A1 AR P040103219 A ARP040103219 A AR P040103219A AR 045612 A1 AR045612 A1 AR 045612A1
- Authority
- AR
- Argentina
- Prior art keywords
- reuptake inhibitor
- inhibitors
- pharmaceutically acceptable
- acceptable salt
- norepinefrine
- Prior art date
Links
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Composiciones farmacéuticas y métodos para tratar la depresión en un mamífero. El método de tratamiento consiste en administrar :(i) al menos un inhibidor de la recaptación de serotonina o una sal farmacéuticamente aceptable del mismo, como por ejemplo sertralina, entre otros; y (ii) al menos un inhibidor de la recaptación de norepinefrina o una sal farmacéuticamente aceptable del mismo como por ejemplo reboxetina entre otros, donde el inhibidor de la recaptación de norepinefrina se selecciona entre el grupo compuesto por la Estructura II, la Estructura III y la Estructura IV como se han definido en este documento. Reivindicación 13: Una composición que consta esencialmente de (i) al menos un inhibidor de la recaptación de serotonina o una sal farmacéuticamente aceptable del mismo, donde el al menos un inhibidor de la recaptación de serotonina es sertralina, que está presente en una cantidad suficiente para inhibir la recaptación de dopamina; y (ii) al menos un inhibidor de la recaptación de norepinefrina o una sal farmacéuticamente aceptable del mismo, donde el al menos un inhibidor de la recaptación de norepinefrina es [S,S]-reboxetina.Pharmaceutical compositions and methods to treat depression in a mammal. The method of treatment consists in administering: (i) at least one serotonin reuptake inhibitor or a pharmaceutically acceptable salt thereof, such as sertraline, among others; and (ii) at least one norepinephrine reuptake inhibitor or a pharmaceutically acceptable salt thereof such as reboxetine among others, where the norepinephrine reuptake inhibitor is selected from the group consisting of Structure II, Structure III and Structure IV as defined in this document. Claim 13: A composition consisting essentially of (i) at least one serotonin reuptake inhibitor or a pharmaceutically acceptable salt thereof, wherein the at least one serotonin reuptake inhibitor is sertraline, which is present in a sufficient amount. to inhibit the reuptake of dopamine; and (ii) at least one norepinephrine reuptake inhibitor or a pharmaceutically acceptable salt thereof, where the at least one norepinephrine reuptake inhibitor is [S, S] -reboxetine.
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US50127503P | 2003-09-09 | 2003-09-09 | |
| US53889804P | 2004-01-23 | 2004-01-23 | |
| US54069604P | 2004-01-30 | 2004-01-30 | |
| US10/769,018 US20050014848A1 (en) | 2002-01-23 | 2004-01-30 | Combination of serotonin reuptake inhibitors and norephinephrine reuptake inhibitors |
| US10/860,721 US20050009927A1 (en) | 2002-01-23 | 2004-06-03 | Combination of serotonin reuptake inhibitors and norepinephrine reuptake inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR045612A1 true AR045612A1 (en) | 2005-11-02 |
Family
ID=42778435
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP040103219 AR045612A1 (en) | 2003-09-09 | 2004-09-08 | COMBINATION OF INHIBITORS OF THE RECOVERY OF SEROTONINE AND INHIBITORS OF THE RECAPTATION OF NOREPINEFRINE |
Country Status (2)
| Country | Link |
|---|---|
| AR (1) | AR045612A1 (en) |
| PE (1) | PE20050375A1 (en) |
-
2004
- 2004-09-07 PE PE2004000863A patent/PE20050375A1/en not_active Application Discontinuation
- 2004-09-08 AR ARP040103219 patent/AR045612A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PE20050375A1 (en) | 2005-05-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE20210668A1 (en) | CARBA-NUCLEOSID ANALOGS REPLACED WITH 2'-FLUORINE ANTIVIRALS | |
| AR054805A1 (en) | TOPICAL COMPOSITIONS FOR SKIN TREATMENT | |
| AR086652A1 (en) | TREATMENT METHODS, PHARMACEUTICAL COMPOSITIONS AND USES OF THE SAME | |
| ES2172744T3 (en) | PHARMACEUTICAL COMPOSITIONS THAT INCLUDE MIRTAZAPINE AND ONE OR VARIOUS SELECTIVE INHIBITORS OF ASSIMILATION OF SEROTONIN. | |
| EA201100896A1 (en) | COMPOSITION INTENDED FOR SUCKING NICOTINE FROM THE FATAL CAVITY WITH THE PURPOSE TO STOP SMOKING | |
| NZ598778A (en) | Combination therapy with SGLT-2 inhibitors and their pharmaceutical compositions | |
| AR059006A1 (en) | COMPOSITIONS OF AN ANTI-CONVULSIVE AND METHODS TO USE THEM TO REVERT THE WEIGHT INCREASE | |
| CO5670327A2 (en) | PROCEDURE FOR THE TREATMENT OF DEPRESSION AND ANXIETY DISORDERS THROUGH COMBINATION THERAPY | |
| AR061289A1 (en) | STABILIZED PHARMACEUTICAL COMPOSITIONS THAT INCLUDE FESOTERODINE | |
| CO5640076A2 (en) | PHARMACEUTICAL COMPOSITION INCLUDED BY AN IBAT INHIBITOR FOR THE TREATMENT OR PROFILAXIS OF THE CONSTIPATION | |
| ECSP088208A (en) | NEW MACROCYCLIC INHIBITORS OF HEPATITIS C VIRUS REPLICATION | |
| AR044007A1 (en) | METHODS FOR THE TREATMENT OF PARKINSON'S DISEASE | |
| AR050717A1 (en) | PHARMACEUTICAL COMPOSITIONS | |
| CO6270215A2 (en) | TRANS-CLOMPHENE FOR METABOLIC SYNDROME | |
| CL2022002592A1 (en) | Use of agents for treatment of respiratory conditions | |
| CL2011001093A1 (en) | Compounds derived from 4- [2- (2-fluorophenoxymethyl) phenyl] piperidine, serotonin and norepinephrine reuptake inhibitors; preparation procedure; pharmaceutical composition that includes them; and its use to treat neuropathic pain, fibromyalgia, depressive disorder and obesity among others. | |
| CR9857A (en) | IRON SUPPLEMENT COMPOSITIONS WITH IMPROVED TOLERANCE | |
| AR084216A1 (en) | COMPOSITIONS AND METHODS TO TREAT CANCER USING A PI3K INHIBITOR AND MEK INHIBITOR, KIT | |
| CL2008003231A1 (en) | Substituted 1,3-dihydro-5-isobenzofurancarbonitrile derivative compounds, selective serotonin reuptake inhibitors; pharmaceutical composition; preparation procedure; Useful in the treatment and / or prevention of premature ejaculation. | |
| CL2010000524A1 (en) | Use of a topical composition comprising 3.75% imiquimod and a pharmaceutically acceptable carrier to prepare a medicament useful for treating genital or perianal warts. | |
| PE20090524A1 (en) | PHARMACEUTICAL COMPOSITION INCLUDING THE COMBINATION OF A TRIAZOLOBENZODIAZEPINE AND A SELECTIVE INHIBITOR AGENT OF SEROTONIN RECAPTURE | |
| CO6400138A2 (en) | ANTICHANCERIGINAL COMPOUND AND PHARMACEUTICAL COMPOSITION CONTAINING IT | |
| AR045423A1 (en) | COMBINATIONS OF ANALYTICS AND ANTIDEPRESSANTS | |
| AR045612A1 (en) | COMBINATION OF INHIBITORS OF THE RECOVERY OF SEROTONINE AND INHIBITORS OF THE RECAPTATION OF NOREPINEFRINE | |
| AR056480A1 (en) | COMPOSITION OF 5-HT1B ANTAGONISTS FOR DEPRESSION, ANXIETY AND COGNITION |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |